Search for: "Patent Docs"
Results 901 - 920
of 1,613
Sorted by Relevance
|
Sort by Date
4 Nov 2009, 4:03 am
(Spicy IP) India approaches WTO as yet another seizure takes place (Spicy IP) UK: IPO issues SPC guide (The SPC Blog) US: Follow-on biologics data exclusivity debate scorecard (Part 1 – Patent Docs) (Part II – Patent Docs) (Part III – Patent Docs) US: 12 Senators write in support of 12-year data exclusivity period (Patent Docs) US: Affordable Health Care for America Act introduced in House; includes biosimilar… [read post]
16 Feb 2008, 2:54 pm
Patent Docs has two posts summarizing the call. [read post]
11 Jan 2011, 11:07 pm
Senators follow House colleagues in making BPCIA exclusivity clarifications; New study suggests benefits of longer drug exclusivity period (FDA Law Blog) US: BPCIA’s principal authors seek to clarify Congressional intent with respect to 12-year exclusivity period; PhRMA/BIO request ‘umbrella exclusivity’ (FDA Law Blog) US: BIO’s IP priorities for 2011 (PatentlyBIOtech) US: BIO survey shows support for DNA-based patents despite some reservations (Patent… [read post]
12 Apr 2024, 12:42 pm
Reg. 21242 (Mar. 27, 2024). [2] WIPO Industrial Design Law and Practice – Draft Articles, art. 3(1)(a)(ix), WIPO Doc. [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
8 Dec 2007, 11:00 am
: (IPKat), United StatesIntellectual Property and Personal Injuries Law: (IPBiz),The myth that patent reform will benefit foreigners at the expense of US manufacturers: (Patent Troll Tracker),Useful list of organisations which are not government trade mark offices: (Trademark blog),Patent Advisory Committee tells Bush that problems are surmountable: (IAM), (More from IAM), (Still more from IAM), (e^(ip))Summary judgment date set… [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs)… [read post]
13 May 2010, 4:58 pm
(Patent Docs) Evista (Raloxifene) – US: Patent infringement complaint following a Paragraph IV certification: Eli Lilly & Company v. [read post]
19 Jan 2011, 2:00 am
– Health Care Reform Bill (Patent Baristas) US: Academic study supports longer data exclusivity term for conventional drugs (Patent Docs) US: PTO sued after denying ‘mildly tardy’ second interim PTE request: Genetics & IVF Institute v Kappos (FDA Law Blog) US: AMP v USPTO – Appellees’ brief (Patent Docs) Products Avodart (Dutasteride) – US: GlaxoSmithKline file patent infringement complaint against Anchen… [read post]
31 Dec 2008, 6:04 am
It is with great thanks that I note those that bring many of the visitors to our site: IP Newsflash Patently-O Orange Book Blog Patent Docs Pharmalot 271 Patent Blog Securing Innovation IP Think Tank AIPLA IP Outline Patent Circle Patent Hawk Genome Technology Online Likelihood of Confusion Above the Law Cafe Pharma Here’s wishing you and yours a great year in 2009! [read post]
16 Aug 2011, 11:35 pm
Opposition Division (Kluwer Patent Blog) US: House legislators lobby to exclude 12-year data exclusivity period from free trade agreement (Patent Docs) US: Legislators urge President to include 12-year data exclusivity period in free trade agreement (Patent Docs) US: AMP v. [read post]
2 Mar 2009, 2:30 am
Dudas, Patent Rules Changes, and Patent Reform - a panel discussion on the Tafas case and patent reform bills recently considered by Congress featuring Chris Singer of McDonnell Boehnen Hulbert & Berghoff, and Patent Docs author, will discuss the Tafas v. [read post]
19 Apr 2011, 5:04 pm
Infosint (IPKat) (PatLit) Clobex (Clobetasol) – US: Galderma, Dermalogix agree to end Clobex suit with Paddock (Patent Docs) Crestor (Rosuvastatin) – US: Palmetto files patent infringement suit against AstraZeneca based on its Crestor product; AstraZeneca files for declaratory judgment of non-infringement and invalidity (Patent Docs) Drospirenone, Ethinylestradiol – UK: Shedding further light on obviousness: Gedeon Richter PC v Bayer… [read post]
24 Aug 2023, 7:00 am
This focus on jobs and GDP has caught the attention of both the Department of Commerce (DoC) and the USPTO. [read post]
10 Jun 2015, 5:17 am
(See Declaration of Stephen Lobbin, Doc. [read post]
13 Jan 2010, 3:00 am
Cobrek Pharmaceuticals, Inc (Patent Docs) Nexium (Esomeprazole) – US: Teva drops patent challenge following settlement agreement with AstraZeneca over Nexium (IP Factor) (GenericsWeb) Nuvigil (Armodafinil) - US: Mylan confirms first-to-file patent challenge relating to sleep-disorder drug (SmartBrief) Nuvigil (Armodafinil) - US: Cephalon sues Watson for patent infringement following Para IV challenge (Patent Docs) (GenericsWeb)… [read post]
23 Dec 2009, 12:40 am
(Patent Docs) US: Science Progress article examines impact of gene patents on research (Patent Docs) US: Gene patenting debate continues: round three – Science Friday public debate on National Public Radio (Patent Docs) Products Circadin (Melatonin) – UK: IPO refuses SPC for Circadin (SPC blog) Dovonex (Calcipoltriol) – UK: EWCA upholds Leo Pharma’s patent: LEO Pharma A/S and LEO… [read post]
12 Oct 2011, 3:46 am
No (FDA Law Blog) US: Patent battle over modified meganucleases heats up: Cellectis v Precision Biosciences (Holman’s Biotech IP Blog) (Patent Docs) US: Landmark NORD report on orphan drugs authored by HP&M Director shows FDA flexibility in approval (FDA Law Blog) Products Embeda (Morphine sulfate, Naltrexone hydrochloride) – US: Pfizer, Alpharma, King Pharma. file patent infringement suit against Watson following Para IV certification… [read post]
29 Jul 2009, 6:45 am
Tafas v Doll (Patent Docs) US: For stem cells, it seems that conception is enough: University of Pittsburgh v Hedrick (Patent Docs) (Patents4Life) US: General Accountability Office report on Bayh-Dole: Leverage to promote commercialisation of federally-funded inventions (PatentBIOtech) US: AlphaVax seeks review of BPAI decision awarding priority of invention to Novartis in interference between patents related to Alphavirus (Patent Docs)… [read post]
27 Apr 2010, 10:58 pm
US: MPEG LA announces formation of gene patent pool (Patent Docs) US: In an amended complaint, plaintiff adds count of false marking where defendants allegedly marked products with plaintiff’s patent number: Tripharma LLC v. [read post]
